Home>Topics>Stocks>CareFusion

CareFusion CFN

  1. All
  2. Commentary
  3. Stock Reports
  4. Fund Reports
  5. Headlines
    1. CareFusion ([[ CFN ]] +0.2%) receives an FDA warning letter regarding a manufacturing site in Mexico where it found violations and that a company follow up dated February 13 was not adequate. The FDA ...

      Headlines

      Tue, 22 May 2012

      CareFusion ( CFN +0.2% ) receives an FDA warning letter regarding a manufacturing site ..... company follow up dated February 13 was not adequate. The FDA claims that CFN 's facility, Productos Urologos de Mexico SA, failed to uphold adequate

    2. Billionaire David Einhorn's Stock Picks

      Headlines

      Tue, 22 May 2012

      By Insider Monkey : by Guan Wang It's time to buy technology stocks. We think tech stocks are grossly undervalued as a sector and most of them have very strong growth prospects. Billionaire hedge fund manager David Einhorn certainly seems to have noticed the great opportunities in the technology ...

    3. New Morningstar Analyst Report - Hospira, Inc.

      Stock Reports

      Thu, 17 May 2012

      stable revenue once hospitals commit to a product. In this relatively concentrated industry, Hospira along with CareFusion CFN and Baxter BAX account for about 60% of all infusion pump sales. These devices have a long life (with a five

    4. Baxter Still Defensive, But Is Now The Time For Offense?

      Headlines

      Tue, 15 May 2012

      By Stephen Simpson : The best thing about Baxter ( BAX ) is that so much of its business comes from oligopolistic markets with pretty steady demand and reimbursement. The worst thing about Baxter is that so much of its business comes from oligopolistic markets with pretty steady demand and ...

    5. Moody's expects an increasing number of healthcare companies to succumb to peer pressure and start paying dividends to satiate investor appetite "for immediate, stable income amid today's low ...

      Headlines

      Mon, 14 May 2012

      investor appetite "for immediate, stable income amid today's low interest rate environment." Names Moody's throws out are Lab Corp. ( LH ), Life Tech ( LIFE ), Celgene ( CELG ), Biogen ( BIIB ) and CareFusion ( CFN ). Post your comment!

    6. What's Wrong With Covidien?

      Headlines

      Fri, 4 May 2012

      By Stephen Simpson : You would think that a company posting roughly double the industry average revenue growth rate and solid margins should be one of the more highly-valued companies in the sector. Alas, that's not the case with Covidien ( COV ). While I don't want to leave readers with the ...

    7. CareFusion ([[ CFN ]] +4.4%) gains after its FQ3 results beat expectations late yesterday. Net earnings actually fell 31% Y/Y on losses related to the disposal of one of its divested businesses, but ...

      Headlines

      Fri, 4 May 2012

      CareFusion ( CFN +4.4% ) gains after its FQ3 results beat expectations late yesterday. Net earnings actually fell 31% Y/Y on losses related

    8. CareFusion's Medical Device Segment Reports Stronger-Than-Expected Results

      Commentary

      Fri, 4 May 2012

      CareFusion CFN reported surprisingly strong third ..... Nicolet operations had little overlap with CareFusion 's other operations, the divestiture ..... quarter's results affirm our thesis on CareFusion 's long-term margin expansion potential

    9. CareFusion's CEO Discusses Q3 2012 Results - Earnings Call Transcript

      Headlines

      Thu, 3 May 2012

      CareFusion ( CFN ) Q3 2012 Earnings Call May 03, 2012 5:00 pm ET Executives Jim Mazzola ..... Good day, ladies and gentlemen, and welcome to the Third Quarter 2012 CareFusion Corporation Earnings Conference Call. My name is Melanie and I'll

    10. Care Fusion ( CFN ): FQ3 EPS of $0.49 beats by $0.04. Revenue of $919M (+9% Y/Y) beats by $23M. (PR)

      Headlines

      Thu, 3 May 2012

      Care Fusion ( CFN ): FQ3 EPS of $0.49 beats by $0.04 . Revenue of $919M (+9% Y/Y) beats by $23M . ( PR ) Post your comment!

    « Prev12345Next »
    Content Partners